Cargando…
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
Tamoxifen, an estrogen receptor (ER) antagonist, is the mainstay treatment of breast cancer and the development of resistance represents a major obstacle for a cure. Although lncRNAs such as HOTAIR have been implicated in breast tumorigenesis, their roles in chemotherapy resistance remain largely un...
Autores principales: | Xue, Xingyang, Yang, Yeqing Angela, Zhang, Ali, Fong, Ka-wing, Kim, Jung, Song, Bing, Li, Shangze, Zhao, Jonathan C., Yu, Jindan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791209/ https://www.ncbi.nlm.nih.gov/pubmed/26364613 http://dx.doi.org/10.1038/onc.2015.340 |
Ejemplares similares
-
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
por: Zhang, Ali, et al.
Publicado: (2015) -
FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function
por: Yang, Yeqing A., et al.
Publicado: (2016) -
Functions of lncRNA HOTAIR in lung cancer
por: Loewen, Gregory, et al.
Publicado: (2014) -
lncRNA HOTAIR functions and therapeutic perspectives
por: Garbo, Sabrina, et al.
Publicado: (2022) -
LncRNA HOTAIR in Tumor Microenvironment: What Role?
por: Botti, Gerardo, et al.
Publicado: (2019)